Jpmorgan Chase & CO Tiziana Life Sciences LTD Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 100 shares of TLSA stock, worth $220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$220% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TLSA
# of Institutions
36Shares Held
3.1MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$3.83 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$368,5920.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$318,7800.0% of portfolio
-
Morgan Stanley New York, NY139KShares$305,8700.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$231,8030.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $225M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...